Condition
Non-Metastatic Neoplasm
Total Trials
4
Recruiting
1
Active
1
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed2
Recruiting1
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06502483Not ApplicableCompleted
PRISM for Depression and Anxiety in Young Adults With Cancer
NCT01280825Recruiting
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
NCT05943301Not ApplicableWithdrawnPrimary
Study of the Impact of Non-pharmacological Techniques on Cognitive Complaints in Cancer Patients
NCT03144154Not ApplicableCompletedPrimary
Impact of an Intervention Combining Self-care and Hypnosis on the Well-being of Cancer Patients and Their Partners
Showing all 4 trials